Understand the source comparison
Epithalon vs NAD+: Which Outperforms? | Real Peptides
A 2023 study from Moscow's Institute of Biogerontology found that epithalon administration increased mean telomere length by 33% in vascular endothelial cells after 10 days of treatment. A result NAD+ supplementation has never replicated because it doesn't tar
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- A 2023 study from Moscow's Institute of Biogerontology found that epithalon administration increased mean telomere length by 33% in vascular endothelial cells after 10 days of treatment. A result NAD+ supplementation has never replicated because it doesn't target telomerase activity. That distinction matters more than most comparison articles acknowledge.
- Our team has worked with researchers across multiple institutions evaluating both compounds for longevity protocols. The question isn't which is 'better'. It's which biological pathway you're attempting to address. Epithalon and NAD+ operate through completely separate mechanisms, target different aspects of cellular aging, and produce non-overlapping outcomes.
- What's the fundamental difference between epithalon and NAD+ for anti-aging research?
- Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) that activates telomerase, the enzyme responsible for lengthening telomeres. The protective DNA caps that shorten with each cell division. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in all living cells that powers mitochondrial energy production and activates sirtuins, proteins involved in DNA repair and metabolic regulation. Epithalon addresses replicative cellular aging at the chromosomal level; NAD+ addresses metabolic decline and energy deficiency. They're complementary, not competing.
- The comparison fails if you're expecting a clear winner. Epithalon works on telomere biology. The Hayflick limit that determines how many times a cell can divide before senescence. NAD+ works on mitochondrial function. The energy-producing capacity that declines 50% between age 40 and 70. This article covers the specific mechanisms each compound activates, the clinical evidence supporting their use, what research shows about combining them, and the scenarios where one demonstrably outperforms the other.